CIK 0001878313
- Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- 4 Open-market buy Director bought 1,500 shares at $3.98 ($5,970)
- 4 Open-market buy Director bought 3,582 shares at $4.03 ($14,435)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,741 shares at an average $4.03 ($11,060)
- 4 Open-market buy Director bought 5,037 shares at an average $4.21 ($21,214)
- 4 Open-market buy Chief Executive Officer bought 1,581 shares at $4.21 ($6,656)
- 4 Open-market buy Director bought 2,215 shares at an average $4.23 ($9,375)
- 4 Open-market buy Director bought 1,352 shares at an average $4.25 ($5,741)
- 4 Open-market buy Chief Executive Officer bought 1,983 shares at $4.24 ($8,408)
- 4 Open-market buy Director bought 7,103 shares at an average $4.40 ($31,283)
- 4 Open-market buy Chief Executive Officer bought 2,443 shares at an average $4.47 ($10,918)
- 4 Open-market buy Director bought 221 shares at an average $4.47 ($988)
- 4 Open-market buy Chief Executive Officer bought 1,557 shares at an average $4.49 ($6,988)
- 4 Open-market buy Director bought 1,838 shares at an average $4.48 ($8,232)
- 4 Open-market buy Director bought 1,301 shares at an average $4.48 ($5,831)
- 4 Open-market buy Chief Executive Officer bought 73 shares at $4.25 ($310)
- 4 Open-market buy Director bought 137 shares at $4.25 ($582)
Page 10 of 13 · 250 filings